March 24, 2025

TPT Lowers Tuberculosis Risk in Rheumatic Patients

TPT decreased the overall risk of tuberculosis disease in patients with rheumatic diseases, with a 76% risk reduction observed in certain subgroups, researchers reported.

Conexiant

March 21, 2025

FDA Approves Guselkumab for Crohn’s Disease

The FDA has approved guselkumab (TREMFYA®) for moderately to severely active Crohn’s disease, supported by Phase 3 trial data showing clinical and endoscopic superiority over ustekinumab.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 14, 2025

CADM Misdiagnosed Twice as Often as DM, Linked to Poorer Outcomes

Study reveals CADM patients face twice the misdiagnosis rate of DM patients, with diagnostic delays associated with increased hospitalization and ILD risks.

Conexiant

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 10, 2025

Misdiagnosis in Autoimmune Disease: Lasting Impact

"I still can't forget those words": More than 80% of patients with SARD who reported psychosomatic misdiagnoses experienced long-term damage to self-worth and trust in clinicians, a new study finds.

Conexiant

March 10, 2025

Lower HCQ Dose Maintains Lupus Remission, Study Finds

With the use of Hydroxychloroquine at stable doses of 200 mg/day, more than 70% of inception patients with systemic lupus erythematosus in our cohort achieved prolonged remission.

Conexiant

March 06, 2025

COVID-19 Increases Autoimmune Blistering Disease Risk, Study Finds

COVID-19 infection significantly increases autoimmune blistering disease risk, while vaccination appears protective, researchers report in a study analyzing 112 million patient records

Conexiant

March 06, 2025

Younger Age, Active SLE, Prednisone Tied to Pericarditis Recurrence

Researchers found that younger age, active systemic lupus erythematosus, and prednisone use significantly increase the risk of recurrent pericarditis in lupus patients.

Conexiant